Fine Lines: Why Allergan’s Botox Ain’t Beat
December 06, 2017 at 10:41 AM EST
Although Allergan fell on data out from rival Revance, it doesn't mean that its Botox product has necessarily been bested.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.